Tao Wan

1.6k total citations
46 papers, 1.1k citations indexed

About

Tao Wan is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Tao Wan has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Surgery and 14 papers in Hepatology. Recurrent topics in Tao Wan's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Tao Wan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Tao Wan collaborates with scholars based in China, Japan and Croatia. Tao Wan's co-authors include Xuetao Cao, Yanming Zhou, Bingyang Hu, Jiahong Dong, Xiaoying Si, Weiping Zhang, Taoyong Chen, Guoyou Chen, Wenying Wang and Yanfeng Wu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Tao Wan

42 papers receiving 1.1k citations

Peers

Countries citing papers authored by Tao Wan

Since Specialization

Citations

This map shows the geographic impact of Tao Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Wan more than expected).

Fields of papers citing papers by Tao Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Wan. The network helps show where Tao Wan may publish in the future.

Co-authorship network of co-authors of Tao Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Wan. A scholar is included among the top collaborators of Tao Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Wan. Tao Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness analysis of direct oral anticoagulants versus low-molecular-weight heparin and no thromboprophylaxis in primary prevention of cancer-associated venous thromboembolism in China 2024 ·Frontiers in Pharmacology ·Yue Wu, (unknown), (unknown), Tao Wan, Benhong Zhou	2
2	Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis 2023 ·HPB ·(unknown), Haowen Tang, Bingyang Hu, Wenwen Zhang, Tao Wan, Jun Han, (unknown), Junfeng Li, Xuerui Li, (unknown), Zhe Liu, Minggen Hu, (unknown), Chenggang Li, Zhiming Zhao, Shichun Lu	11
3	Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma 2023 ·World Journal of Surgical Oncology ·Ze Zhang, (unknown), Junfeng Li, Bingyang Hu, Wenwen Zhang, Zhijun Wang, Tao Wan, Yafei Wang, Shichun Lu	6
4	Factors influencing the prognosis patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma undergoing salvage surgery after conversion therapy 2023 ·Translational Cancer Research ·Yingwei Pan, Li Yang, (unknown), Jun Han, Haowen Tang, Wenwen Zhang, Tao Wan, (unknown), Bingyang Hu, Shichun Lu	4
5	Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability 2022 ·Frontiers in Oncology ·(unknown), Wenying Wang, (unknown), Jia Xu, Rongrong Xu, Tao Wan, Yanfeng Wu	10
6	Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma 2022 ·Frontiers in Cell and Developmental Biology ·Ze Zhang, Wenwen Zhang, Yafei Wang, Tao Wan, Bingyang Hu, Chonghui Li, (unknown), Shichun Lu	27
7	Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis 2018 ·BMC Cancer ·Debang Li, Bin Hu, Yanming Zhou, Tao Wan, Xiaoying Si	24
8	Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review 2018 ·Asian Journal of Surgery ·Debang Li, Xiaoying Si, Tao Wan, Yanming Zhou	15
9	A pooled analysis of en bloc right hemicolectomy with pancreaticoduodenectomy for locally advanced right-sided colon cancer 2018 ·International Journal of Colorectal Disease ·Debang Li, Xiaoying Si, Tao Wan, Yanming Zhou	9
10	A pooled analysis of treatment and prognosis of hepatic angiosarcoma in adults 2018 ·Hepatobiliary & pancreatic diseases international ·Debang Li, Xiaoying Si, Tao Wan, Yanming Zhou	18
11	Drag Reduction Optimization for Hypersonic Blunt Body with Aerospikes 2017 ·HAL (Le Centre pour la Communication Scientifique Directe) ·Tao Wan, Liu Cm	2
12	Effect of infrahepatic inferior vena cava clamping on bleeding during hepatic resection: A meta-analysis 2017 ·Asian Journal of Surgery ·Yanming Zhou, Zuobing Zhang, Tao Wan	5
13	Risk factors for postoperative pancreatic fistula: Analysis of 539 successive cases of pancreaticoduodenectomy 2016 ·World Journal of Gastroenterology ·Bingyang Hu, Tao Wan, (unknown), Jiahong Dong	111
14	Clinicopathological Characteristics and Prognostic Factors of Intrahepatic Biliary Cystadenocarcinoma 2015 ·Chinese Medical Journal ·Mingyue Xu, Xianjie Shi, Tao Wan, Yurong Liang, Hongguang Wang, Wenzhi Zhang, Lei He, Mingyi Chen, Shaocheng Lyu, Wen‐Wen Zhang, Huixing Li	11
15	Role of glyceraldehyde-3-phosphate dehydrogenase binding to hepatitis B virus posttranscriptional regulatory element in regulating expression of HBV surface antigen 2009 ·Archives of Virology ·(unknown), (unknown), Xiaohua Zhang, Tao Wan, Jieli Hu, Ailong Huang, Hua Tang	14
16	DC-CLM, a cadherin-like molecule cloned from human dendritic cells, inhibits growth of breast cancer cells 2003 ·Journal of Cancer Research and Clinical Oncology ·Yingming Jiang, Tao Wan, Guoyou Chen, Fangming Xiu, Dajing Xia, Weiping Zhang, Xiangyang Zhou, Xuetao Cao	4
17	Rab39, a novel Golgi-associated Rab GTPase from human dendritic cells involved in cellular endocytosis 2003 ·Biochemical and Biophysical Research Communications ·Taoyong Chen, Yanmei Han, Mingjin Yang, Weiping Zhang, Nan Li, Tao Wan, Jun Guo, Xuetao Cao	41
18	Cloning and functional characterization of ACAD-9, a novel member of human acyl-CoA dehydrogenase family 2002 ·Biochemical and Biophysical Research Communications ·Jia Zhang, Weiping Zhang, (unknown), Guoyou Chen, Tao Wan, Minghui Zhang, Xuetao Cao	78
19	Identification and Characterization of DPZF, a Novel Human BTB/POZ Zinc Finger Protein Sharing Homology to BCL-6 2001 ·Biochemical and Biophysical Research Communications ·Wei‐Ping Zhang, Jing Mi, Nan Li, (unknown), Tao Wan, Jia Zhang, Taoyong Chen, Xuetao Cao	63
20	Molecular Cloning and Characterization of a Novel CXC Chemokine Macrophage Inflammatory Protein-2γ Chemoattractant for Human Neutrophils and Dendritic Cells 2000 ·The Journal of Immunology ·Xuetao Cao, Weiping Zhang, Tao Wan, Long He, Taoyong Chen, Zhenglong Yuan, (unknown), Yizhi Yu, Guoyou Chen	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact